PODD — Insulet Corp. stock price, charts and financials

QT31Insulet Corp.

Insulet Corp. (NASDAQ: PODD) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
166.82
-2.88-1.70%
OverviewShort InterestFilings
PODDQT31Insulet Corp.·NASDAQ
166.82-1.70%
Earnings
Down 1.7% — Reported earnings — EPS beat by 18%, revenue beat by 4%.
High confidence
TA
Loading chart...
Screen all →
GMED+0.06%$81.51ALGN+0.22%$173.27PEN+0.37%$324.22SNN-5.32%$30.44GKOS-0.20%$170.53MASI+0.00%$179.95BIO-0.55%$332.88BRKR-21.79%$50.30
Snapshot
IndexS&P 500P/E38.80EPS (ttm)4.30Insider Own0.87%Shs Outstand69.26MPerf Week-0.39%
Market Cap11.55BForward P/E20.71EPS next Y8.05Insider Trans1.44%Shs Float68.96MPerf Month4.41%
Enterprise Value12.02BPEG1.77EPS next Q-Inst Own-Short Float6.74%Perf Quarter-2.67%
Income304.00MP/S3.98EPS this Y50.76%Inst Trans-Short Ratio3.02Perf Half Y-34.99%
Sales2.90BP/B8.87EPS next Y24.25%ROA10.14%Short Interest4.65MPerf YTD-41.31%
Book/sh18.81P/C24.07EPS next 5Y21.96%ROE21.38%52W High354.86 -52.99%Perf Year-41.45%
Cash/sh6.93P/FCF27.78EPS past 3/5Y275.36% 103.38%ROIC16.39%52W Low138.79 20.20%Perf 3Y-40.53%
Dividend Est.-EV/EBITDA20.95Sales past 3/5Y27.55% 24.54%Gross Margin71.01%Volatility3.73% 3.47%Perf 5Y-37.49%
Dividend TTM-EV/Sales4.14EPS Y/Y TTM-25.61%Oper. Margin17.48%ATR (14)6.56Perf 10Y389.78%
Dividend Ex-Date-Quick Ratio1.81Sales Y/Y TTM40.01%Profit Margin10.44%RSI (14)55.48Recom2.36
Dividend Gr. 3/5Y-Current Ratio2.49EPS Q/Q39.22%SMA202.08%Beta1.08Target Price211.21
Payout0.00%Debt/Eq0.69Sales Q/Q33.92%SMA507.08%Rel Volume1.12Prev Close169.70
Employees5,400LT Debt/Eq0.68EarningsAug 05SMA200-27.68%Avg Volume1.56MPrice166.82
IPO DateMay 15, 2007Option/ShortYes / YesEPS/Sales Surpr.18.46% 4.36%Net Debt/EBITDA0.81Volume1,748,219Change-1.70%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-28-26ReiteratedUBSBuy$219 → $174
Jul-13-26ReiteratedRBC CapitalOutperform$280 → $245
Jul-13-26ReiteratedTruist SecuritiesBuy$219 → $210
Jul-10-26ReiteratedStifel Nicolaus$250 → $225
Jul-06-26ReiteratedEvercore ISI GroupOutperform$200 → $180
Jun-23-26InitiatedDeutsche BankBuy$190
Jun-11-26ReiteratedUBSBuy$250 → $219
Jun-08-26ReiteratedRaymond JamesOutperform$263 → $216
May-27-26ReiteratedGoldman SachsBuy$237 → $205
May-07-26ReiteratedGoldman SachsBuy$277 → $237
Latest News
Aug-04-26
Aug-04-2607:00PM
PODD INVESTOR REMINDER: Insulet Corporation Investors Have Until August 31, 2026 To Seek Lead Plaintiff Rolebusinesswire.com
04:45PM
Pomerantz Law Firm Announces the Filing of a Class Action Against Insulet Corporation and Certain Officers – PODDglobenewswire.com
04:41PM
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Insulet Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – PODDglobenewswire.com
02:15PM
DEADLINE ALERT for PODD, MVST, HUBG: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actionsglobenewswire.com
01:48PM
PODD DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Insulet (PODD) Investors of Securities Class Action Lawsuit Deadline on August 31, 2026newsfilecorp.com
01:40PM
Deadline Alert: Insulet Corporation (PODD) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuitglobenewswire.com
12:47PM
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Insulet Corporation (PODD)globenewswire.com
11:01AM
PODD Deadline Alert: SueWallSt Reminds Insulet Corporation (PODD) Investors of Securities Class Action Deadline on August 31, 2026globenewswire.com
10:21AM
PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit with SBS Lawglobenewswire.com
10:09AM
The Gross Law Firm Reminds Insulet Corporation Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 31, 2026 - PODDprnewswire.com
06:36AM
PODD Stock Drop: Insulet Safety Issues Lead to 6% Stock Drop and Securities Fraud Class Action for Investorsprnewswire.com
Aug-03-26
Aug-03-2612:00PM
Bronstein, Gewirtz & Grossman LLC Urges Insulet Corporation Investors to Act: Class Action Filed Alleging Investor Harmglobenewswire.com
10:15AM
PODD UPCOMING DEADLINE: Levi & Korsinsky Alerts Insulet Corporation Stockholders of Securities Class Action - Contact the Firmglobenewswire.com
10:05AM
Robbins LLP Reminds Insulet Corporation (NASDAQ: PODD) Investors Who Suffered Significant Losses of the Securities Fraud Class Actionprnewswire.com
06:36AM
PODD Class Action Notice: Insulet Hit with Securities Fraud Lawsuit over Safety Misrepresentations – Investors Urged to Contact BFA Law by August 31 Deadlineglobenewswire.com
Company

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue2,9012,7082,0721,6971,3051,099904738564
Cost of Goods Sold Incl. D&A841768626537500347322258194
Gross Profit2,0601,9401,4461,160806752582480370
Selling, General and Administrative Excl. Other1,2211,165917735588466384298248
Research and Development33130122020518016014713289
Other Operating Expense000000006
Operating Income50747430922038126525027
Interest Expense718043363662483522
Unusual Expense
—————————
Non-Operating Income (Expense)-32-5534318-446-10
Net Income Before Taxes404340300215102110155
Income Taxes10292-118854332
Consolidated Net Income3042474182065177123
Net Income From Continuing Operations3042474182065177123
Net Income3042474182065177123
EPS (Recurring)4.313.515.972.960.070.250.110.190.06
EPS (Basic, Before Extraordinaries)4.313.515.972.960.070.250.110.190.06
EPS (Diluted)4.303.485.782.940.070.250.100.190.05
EBITDA5745324243241091401107447
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio38.8081.6845.1773.804,474.011,064.282,556.30901.051,468.89
Price To Sales Ratio4.037.358.828.9515.5716.4618.3814.158.30
Gross Margin71.0171.6469.7968.3661.7668.4364.3865.0465.60
Operating Margin17.4817.5014.9112.962.9111.465.756.784.79
Net Margin10.489.1220.1712.140.381.550.771.630.53
Shares Outstanding707070706968656159
Market Capitalization11,67719,89718,27515,18920,31318,09316,61610,4434,680
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$384.90$315.40$245.89$176.39$106.89● Close Price0.00M0.46M0.92M1.38M1.85MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
STONESIFER TIMOTHY C.DirectorJun 03 '26Buy143.512,790400,3939,041Jun 04
BORIO LUCIANADirectorJun 03 '26Sale143.2741859,8874,329Jun 04
MINOGUE MICHAEL RDirectorFeb 25 '26Buy246.232,030499,84717,483Feb 26
McEvoy AshleyPresident and CEOFeb 20 '26Buy239.354,3001,029,20513,916Feb 23
Frederick Wayne A.I.DirectorDec 15 '25Sale293.091,851542,5102,158Dec 16
STONESIFER TIMOTHY C.DirectorDec 05 '25Buy311.73962299,8844,591Dec 08
Cousin LaetitiaSVP, Reg, Quality & ComplianceSep 08 '25Sale348.81797278,0023,890Sep 09
Singh PremSVP, Global OperationsSep 08 '25Sale347.49687238,7263,456Sep 09
Cousin LaetitiaSVP, Reg, Quality & ComplianceSep 08 '25Option Exercise241.10797192,1614,687Sep 09
Benjamin EricEVP, CPXOAug 21 '25Sale332.234,2631,416,29616,736Aug 22
Singh PremSVP, Global OperationsAug 07 '25Option Exercise271.281,343364,3255,486Aug 08
Singh PremSVP, Global OperationsAug 07 '25Sale320.001,343429,7604,143Aug 08
Singh PremSVP, Global OperationsJun 13 '25Option Exercise166.621,257209,4416,470Jun 16
Singh PremSVP, Global OperationsJun 13 '25Sale300.052,327698,2164,143Jun 16
Manea DanSVP, Chief HR OfficerJun 13 '25Sale300.051,300390,0659,090Jun 16
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.